On World AIDS Day, Richard Tren argues that the health crisis in poor countries is not caused by drug patents, but by poverty and a lack of health infrastructure. Rich countries should be lowering trade barriers and not undermining drug patents in the name of bettering healthcare.
DDT Still Saving Lives -- Richard Tren, United Press International, 2002-11-11
Richard Tren writes on the recent UNEP workshop held in Pretoria for African Countries to develop plans to reduce or eliminate persistent organic pollutants (POPS).
Weapon against malaria is ignored -- Richard Tren, Financial Times, 2002-11-07
Richard Tren's letter to the Financial Times commenting on recent calls to increase funding and resources to fight malaria.
Southern Africa Beating Malaria -- Patrick Leeman, AllAfrica.com, 2002-11-05
Article in the Argus Newspaper (South Africa), reproduced on AllAfrica.com explaining the successes in malaria control in Southern Africa.
Nigeria AIDS drug deal soured -- Dr. Roger Bate, United Press International, 2002-11-04
Dr. Roger Bate explains how the importation of generic versions of patented AIDS drugs to Nigeria has done little to improve treatment in this West African country.
AIDS activists' new complaint not helpful -- Richard Tren, Business Day, 2002-10-02
Richard Tren on the Aids Activists\' Competition Commission case against GSK and Boehringer Ingelheim.
Barun Mitra and Richard Tren write about the importance of patent protection in disease control. They argue that in poor countries, patents do not hinder access to essential drugs and they are vital in creating incentives for and giving security to innovators.
Giving Tolerance a Bad Name -- Richard Tren, TechCentral Station, 2002-09-03
"The thin line between Robert Mugabe and the activists."